Navigation Links
Generic Pharmaceuticals Offer Exciting Growth Opportunities in Tanzania, Reveals Frost & Sullivan

CAPE TOWN, South Africa, April 16 /PRNewswire/ -- The pharmaceuticals market in Tanzania presents significant growth opportunities for local companies. Generic drug production is driving prices down, resulting in higher uptake.


New analysis from Frost & Sullivan (, Strategic Analysis of the Healthcare Industry in Tanzania, finds that the pharmaceutical market earned revenues of $105.0 million in 2007 and estimates this to reach $188.0 million in 2014.

If you are interested in a virtual brochure, which provides a brief synopsis of the research and a table of contents, then send an e-mail to Patrick Cairns, Corporate Communications, at, with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country. Upon receipt of the above information, a brief brochure will be sent to you by e-mail.

"Growth in the Tanzanian pharmaceuticals industry will be boosted by the expected decline in drug prices, due to the increased availability of generic drugs," notes Frost & Sullivan Research Analyst Ishe Zingoni. "This would facilitate higher uptake of drugs and promote the local manufacturing industry."

Government support has been crucial in stimulating the infant local pharmaceuticals sector. Localisation of drug manufacturing is driving prices of some drug classes down, and as the industry reaches sufficient economies of scale, prices are predicted to further decrease.

The main restraint in this market is the intensifying level of competition from low cost imports. Local manufacturing is also hindered extensively by the lack of technical skills in production.

"Manufacturers in Tanzania cannot get local expertise and, therefore, rely on Indian and British expatriates for the technical aspects of production," adds Zingoni. "Local employees only focus on packaging and labeling processes."

Some local manufacturers are entering strategic agreements with Thai partners to facilitate technical skills transfer and procure raw materials. Together with their partners, Tanzanian companies are increasingly investing in generating local expertise through training programmes.

Strategic Analysis of the Healthcare Industry in Tanzania is part of the Medical Devices Growth Partnership Service programme, which also includes research in the following markets: Strategic Analysis of the Healthcare Industry of Kenya, Key Infectious Diseases Markets in East Africa, Strategic Analysis of Oncology Services in Key Sub-Saharan African Countries and, Infectious Disease Pharmaceutical Markets in key Sub-Saharan African Countries. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents. To join our Growth Partnership, please visit

           Strategic Analysis of the Healthcare Industry in Tanzania

    Patrick Cairns
    Corporate Communications - Africa
    P: +27 18 468 2315

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. 2008 Sees Significant Rise in Prescription Abandonment and Uptake of Generics
2. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Topamax(R) Tablets
3. Zydus Pharmaceuticals (USA) Inc. Announces FDA Final Approval for the Generic Version of Topamax(R) Tablets
4. GPhA Statement on the Introduction of the Bipartisan Senate Biogenerics Consensus Bill: Promoting Innovation and Access to Life-Saving Medicine Act
5. Consumer, Business and Labor Groups Endorse Bipartisan Senate Bill Authorizing Biogenerics
6. Mylans Matrix Receives Tentative FDA Approval Under PEPFAR for First Generic, Heat-Stable Version of HIV Protease Inhibitor
7. Prasco Selected as GSKs Generics Marketing and Distribution Agent
8. Thomson Reuters Publishes Pharma Matters White Paper, The Five Myths of Generic Competition
9. Lilly Granted Temporary Restraining Order to Halt Launch of Generic Raloxifene
10. D&W Fresh Markets, Family Fare and VGs Expand Discounted Generic Drug Program
11. GPhA Praises President Obamas Support for Safe and Affordable Biogenerics as Critical Solution to Americas Ailing Health Care System
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... The rapid ... America. As people age, more care is needed, especially with Alzheimer’s, dementia and ... professionals are being overworked. The forgotten part of this equation: 80 percent of ...
(Date:11/27/2015)... ... November 27, 2015 , ... The print component of ... in Atlanta, Dallas, New York, Minneapolis, South Florida, with a circulation of approximately ... nationally, through a vast social media strategy and across a network of top ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... A simply ... Jones, is an interesting show that delves into an array of issues that are ... that could benefit from open dialogue, this show is changing the subjects consumers focus ...
(Date:11/27/2015)... ... , ... Dr. Thomas Dunlap and Dr. Patrick Coleman , ... Emergency Medicine at St., Joseph Health System’s Santa Rosa Memorial Hospital , co-hosted ... similar ways and require time-critical intervention to avoid large area heart damage and progressive ...
(Date:11/26/2015)... ... November 26, 2015 , ... CognisantMD and ... diagnostic imaging in the Waterloo region. Using the Ocean Platform, family physicians can ... from their electronic medical record (EMR) without the need for redundant patient entry ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... DUBLIN , Nov. 26, 2015 /PRNewswire/ ... announced the addition of the "2016 ... by Test, Country Volume and Sales Segment ... Emerging Opportunities" report to their offering. ... the addition of the "2016 Global ...
(Date:11/26/2015)... --> --> ... immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer.   ... with Bremachlorin-photodynamic therapy for advanced cancer.   ... with Bremachlorin-photodynamic therapy for advanced cancer.   ... immunotherapy can be efficiently combined with photodynamic therapy (PDT) ...
(Date:11/26/2015)... FRANCISCO , November 26, 2015 ... billion by 2022, according to a new report by Grand ... Chronic Kidney Disease (CKD) which demands kidney transplantation is expected ... and cost effective substitute for organ transplantation. --> ... billion by 2022, according to a new report by Grand ...
Breaking Medicine Technology: